Tumours modulate the systemic vascular response to anti‐angiogenic therapy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Applied Toxicology"
DOI: 10.1002/jat.4301
Abstract: Toxicologic evaluation of new drug candidates routinely utilizes healthy animals. In oncology, there remains a limited understanding of the effects of novel test candidates in a diseased host. For vascular modulating agents (VMAs), an increased… read more here.
Keywords: tumour host; growth; modulate systemic; anti angiogenic ... See more keywords